International Stem Cell Corp. (OTCMKTS:ISCO – Get Free Report) was the recipient of a significant growth in short interest in July. As of July 31st, there was short interest totaling 1,770 shares, a growth of 178.7% from the July 15th total of 635 shares. Based on an average trading volume of 58,000 shares, the short-interest ratio is currently 0.0 days. Currently, 0.1% of the company’s shares are sold short.
International Stem Cell Trading Up 12.9%
Shares of International Stem Cell stock traded up $0.04 during trading on Friday, hitting $0.35. 407 shares of the stock traded hands, compared to its average volume of 22,432. International Stem Cell has a 52-week low of $0.12 and a 52-week high of $0.48. The stock’s fifty day simple moving average is $0.22 and its 200 day simple moving average is $0.18. The firm has a market cap of $2.80 million, a P/E ratio of -4.38 and a beta of -0.03.
International Stem Cell (OTCMKTS:ISCO – Get Free Report) last posted its earnings results on Thursday, August 13th. The biotechnology company reported ($0.01) EPS for the quarter. The business had revenue of $2.67 million for the quarter.
About International Stem Cell
International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.
In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.
See Also
- Five stocks we like better than International Stem Cell
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
